Our group consists of undergraduate students, graduate students, postdoctoral fellows and senior researchers. With different educational backgrounds and complementary experimental expertise, we are dedicated to decipher the cellular and molecular mechanisms underlying the development and progression of many cardiovascular and metabolic diseases. Our devotion, the state of art research platforms, as well as our both national and international collaborations together create an excellent scientific environment for us to achieve this objective.
In the concept of “From Bench to Bed”, we are adopting many molecular biologic, pharmacologic and systemic biologic technologies to explore the novel therapeutic targets in the treatment of many human cardiovascular and metabolic diseases. We wish our work would eventually improve current therapeutic strategy for the treatment of atherosclerosis, diabetic complications and many other diseases.